HRT Financial’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-820,616
Closed -$38.5M 2940
2024
Q2
$38.5M Buy
+820,616
New +$41.3M 0.22% 66
2024
Q1
Sell
-99,991
Closed -$4.39M 2879
2023
Q4
$4.39M Buy
+99,991
New +$4.56M 0.03% 341
2023
Q2
Sell
-20,026
Closed -$722K 3037
2023
Q1
$722K Sell
20,026
-12,112
-38% -$534K 0.01% 1139
2022
Q4
$1.63M Sell
32,138
-557,578
-95% -$29.1M 0.02% 687
2022
Q3
$27.1M Sell
589,716
-182,041
-24% -$8.7M 0.29% 56
2022
Q2
$34.1M Buy
+771,757
New +$39.8M 0.37% 35
2021
Q4
Sell
-133,501
Closed -$4.39M 3841
2021
Q3
$4.39M Buy
+133,501
New +$3.69M 0.03% 356
2021
Q2
Sell
-91,828
Closed -$2.19M 3344
2021
Q1
$2.19M Buy
+91,828
New +$1.96M 0.02% 571
2020
Q1
Sell
-6,011
Closed -$140K 1196
2019
Q4
$140K Buy
+6,011
New +$129K 0.01% 992
2019
Q1
Sell
-7,559
Closed -$218K 712
2018
Q4
$218K Buy
+7,559
New +$326K 0.03% 452
2018
Q3
Sell
-3,507
Closed -$228K 471
2018
Q2
$228K Buy
+3,507
New +$220K 0.08% 186
2016
Q4
Sell
-2,484
Closed -$130K 109
2016
Q3
$130K Buy
+2,484
New +$111K 0.11% 99
2016
Q1
Sell
-2,925
Closed -$74K 90
2015
Q4
$74K Buy
+2,925
New +$107K 0.09% 61

Other funds holding OVV

HRT Financial's OVV Position: Q3 2024 in Review

HRT Financial sold out of Ovintiv (OVV) in Q3 2024, closing a stake of 820,616 shares — an estimated $38.5M sold.

HRT Financial first reported a position in OVV in Q4 2015 and held it in 13 quarters. The position peaked at $38.5M in Q2 2024. 549 funds tracked by Wall St. Rank hold OVV as of Q3 2024.

  • HRT Financial reported no remaining Ovintiv position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 820,616 Ovintiv shares in Q3 2024, an estimated $38.5M.
  • HRT Financial first reported a position in Ovintiv in Q4 2015 and held it in 13 quarters.
  • HRT Financial's Ovintiv position peaked at $38.5M in Q2 2024.
  • 549 funds tracked by Wall St. Rank held Ovintiv as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.